Key result
Among patients hospitalized for COPD exacerbation, the presence of atrial fibrillation was independently associated with increased in-hospital mortality (OR 1.44).
Why the study?
The impact of atrial fibrillation on in-hospital outcomes, including mortality, in patients hospitalized for COPD exacerbation is not well elucidated.
Does atrial fibrillation increase mortality and resource utilization in patients hospitalized for COPD exacerbation?
Observational (n=1,377,795)
Yes
Does atrial fibrillation increase mortality and resource utilization in patients hospitalized for COPD exacerbation?
Odds Ratio: 1.44 (95% CI 1.33–1.56)
Absolute Event Rate: 2.4% vs 1%
p-value: p=<0.001
In patients hospitalized for COPD exacerbation, the presence of atrial fibrillation is independently associated with significantly higher in-hospital mortality, longer length of stay, and increased healthcare costs.
AF associated with higher mortality and costs in COPD exacerbation; supports risk stratification but leaves open whether AF interventions modify outcomes.
INTRODUCTION: Chronic Obstructive Pulmonary Disease (COPD) is a major cause of hospitalization and is associated with an increased incidence of atrial fibrillation (AF). The impact of AF on in-hospital outcomes, including mortality, in patients hospitalized for COPD exacerbation is not well elucidated. METHODS: We used the National Inpatient Sample database to examine discharges with the primary diagnosis of COPD exacerbation and compared mortality, length of stay and costs in patients with AF compared to those without AF. The study adjusted the outcomes for known cardiovascular risk factors and confounders using logistic regression and propensity score matching analysis. RESULTS: Among 1,377,795 discharges with COPD exacerbation, 16.6% had AF. Patients with AF were older and had more comorbidities. Mortality was higher (2.4%) in the AF group than in the no AF group (1%), p <0.001. After adjustment to age, sex and confounders, AF remained an independent predictor for mortality, OR:1.44 (95% CI 133 - 1.56, p <0.001), prolonged length of stay, OR:1.63 (95% CI 1.57 - 1.69, p <0.001) and increased cost, OR: 1.45 (95% CI: 1.40 - 1.49, p <0.001). CONCLUSIONS: among patients with COPD exacerbation, AF was associated with increased mortality and higher resource utilization.
No takes yet. Share an insight, caveat, or question.
Abdullah et al. (2019) conducted an observational in COPD exacerbation (n=1,377,795). Atrial fibrillation vs. No atrial fibrillation was evaluated on In-hospital mortality (OR 1.44, 95% CI 1.33-1.56, p=<0.001). Among patients hospitalized for COPD exacerbation, the presence of atrial fibrillation was independently associated with increased in-hospital mortality (OR 1.44).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: